Sentence examples for difficulties firms from inspiring English sources

Employers who hesitated in hiring older workers also mentioned factors such as wages and non-wage labor costs that rise more steeply with age and the difficulties firms may face in adjusting working conditions to meet the requirements of employment protection rules (Keese et al. 2006).

Critics say this is further evidence of inflexible European labour markets, as it reflects the difficulty firms have in laying off unwanted workers.

Economists usually blame recessions at least partly on the difficulty firms have in cutting wages when demand dries up; that problem was not much on display in Britain.So Labour and the Conservatives go into this election talking across each other.

Yet, despite its desire for foreign investment, Russia's government has yet to push through the Duma sufficient legal protection for these contracts.When oil meets politicsTo add to their difficulties, western firms have found themselves increasingly entangled in arguments between the government and the Russian industry.

The difficulties small firms have in partnering MNCs also reflect the context of outsourcing: the need for scale to cut costs for labor-intensive services.

Forrester Research Analyst Joe Sawyer issued a report today predicting that "The difficulties that firms like CDnow and Peapod now face will only become more widespread.

Consequently, trade credit seems to relieve the difficulties of firms that, as a consequence of information asymmetries, face restrictions in their access to the capital market and suffer credit rationing imposed by banks.9.9

This situation creates uncertainty and could pose difficulties for firms attempting to raise funds.

The arctic weather that struck Britain yesterday could cost the UK economy about £1.2bn, piling further difficulty on firms already struggling in the recession.

The difficulty other firms experience in imitating these successful firms' resources is explained by the amount of time it takes to create and develop them (often decades), as well as the difficulty (in the case of embeddedness) others experience in identifying them as sources of competitive advantage.

The need to prove bioequivalence (the measure of the equivalence of difference formulations of a drug in terms of bioavailability in the body) was another requirement causing difficulty for firms due to lack of any facility for this on the continent outside South Africa.